Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as "chemotherapy" and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, ...

Therapeutic Kinase Inhibitors 2014, Springer

ISBN-13: 9783642445804

2012 edition

Trade paperback

Select
Therapeutic Kinase Inhibitors 2012, Springer

ISBN-13: 9783642282959

2012 edition

Hardcover

Select